ArticleMicrobial cell factories2026
Novel utilization of the seaweed-based deoxy sugars rhamnose and fucose by engineered Corynebacterium glutamicum.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seaweed represents a potential sustainable carbon source for industrial biotechnology, yet the workhorse bacterium Corynebacterium glutamicum cannot naturally metabolize the deoxy sugars L-rhamnose and L-fucose, abundant in green and brown seaweed, respectively. Expanding its substrate range is crucial for sustainable bioprocessing, by enabling utilization of the available biomass. In this study, we engineered C. glutamicum to utilize L-rhamnose and L-fucose by introducing the Escherichia coli operons rhaBADM and fucIKUA, enabling growth on these sugars as sole carbon sources. To enhance growth, we evaluated various transport systems and identified the non-native fucose permease (FucP) as the most efficient for L-rhamnose uptake, and the native myo-inositol transporter 2 (IolT2) as optimal for L-fucose uptake. During L-rhamnose and L-fucose utilization, L-lactaldehyde is formed as a byproduct. We demonstrate that the native acetaldehyde dehydrogenase encoded by ald also exhibits lactaldehyde dehydrogenase activity, and that its overexpression enhances L-lactaldehyde utilization. Finally, cultivation on green and brown seaweed hydrolysates enabled the engineered strains to achieve increased biomass formation through consumption of the targeted deoxy sugars. This study expands the substrate spectrum of C. glutamicum through pathway engineering, transport optimization, and functional identification of a native lactaldehyde dehydrogenase. Growth and L-lysine production on seaweed hydrolysates highlights the potential of this approach for sustainable marine biomass valorization and bioproduction of value-added compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.